Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak

被引：0
|
作者：
Massimo Nicolò
Lorenzo Ferro Desideri
Matteo Bassetti
Carlo Enrico Traverso
机构：
[1] University Eye Clinic of Genoa,IRCCS Ospedale Policlinico San Martino
[2] University of Genoa,Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI)
[3] Macula Onlus Foundation,Infectious Diseases Clinic, Department of Health Sciences
[4] University of Genova and Ospedale Policlinico San Martino- IRCCS Per L’Oncologia,undefined
来源：
International Ophthalmology | 2021年 / 41卷
关键词：
Hydroxychloroquine; Chloroquine; Retina; Retinal safety; COVID-19; Coronavirus; SARCoV-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：719 / 725
页数：6
相关论文
共 50 条
  • [31] Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
    Mohammad Bahadoram
    Bijan Keikhaei
    Ali Saeedi-Boroujeni
    Mohammad-Reza Mahmoudian-Sani
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 997 - 1001
  • [32] Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19
    Piszczatoski, Christopher R.
    Powell, Jason
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 827 - 831
  • [33] Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
    Li Zou
    Lijun Dai
    Xingyu Zhang
    Zhaohui Zhang
    Zhentao Zhang
    Archives of Pharmacal Research, 2020, 43 : 765 - 772
  • [34] USE OF CHLOROQUINE OR HYDROXYCHLOROQUINE IN TREATMENT OF COVID-19: IS IT ETHICAL?
    Allam, Mohamed Farouk
    Andraous, Fady
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 28 (03) : 246 - 247
  • [35] Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
    Gupta, Anunay
    Malviya, Amit
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1152) : 676 - 677
  • [36] Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
    Colson, Philippe
    Rolain, Jean-Marc
    Lagier, Jean-Christophe
    Brouqui, Philippe
    Raoult, Didier
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (04)
  • [37] Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
    Sun, JingKang
    Chen, YuTing
    Fan, XiuDe
    Wang, XiaoYun
    Han, QunYing
    Liu, ZhengWen
    POSTGRADUATE MEDICINE, 2020, 132 (07) : 604 - 613
  • [38] Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
    Qiuyu Li
    Cheng Cui
    Fei Xu
    Jianping Zhao
    Nan Li
    Haichao Li
    Tianbing Wang
    Hua Zhang
    Na Liu
    Yudong Wei
    Xiaoye Niu
    Yan Xu
    Jianping Dong
    Xueting Yao
    Xiaohong Wang
    Yahong Chen
    Haiyan Li
    Chunli Song
    Jie Qiao
    Dongyang Liu
    Ning Shen
    Science China(Life Sciences) , 2021, (04) : 660 - 663
  • [39] Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
    Li, Qiuyu
    Cui, Cheng
    Xu, Fei
    Zhao, Jianping
    Li, Nan
    Li, Haichao
    Wang, Tianbing
    Zhang, Hua
    Liu, Na
    Wei, Yudong
    Niu, Xiaoye
    Xu, Yan
    Dong, Jianping
    Yao, Xueting
    Wang, Xiaohong
    Chen, Yahong
    Li, Haiyan
    Song, Chunli
    Qiao, Jie
    Liu, Dongyang
    Shen, Ning
    SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (04) : 660 - 663
  • [40] Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine
    Latarissa, Irma Rahayu
    Khairinisa, Miski Aghnia
    Iftinan, Ghina Nadhifah
    Meiliana, Anna
    Sormin, Ida Paulina
    Barliana, Melisa Intan
    Lestari, Keri
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2025, 17 : 1 - 11
12345